We conducted detailed genetic analyses of the haemagglutinin-neuraminidase (HN) gene in 272 human parainfluenza virus type 3 (HPIV3) isolates from children with acute respiratory illness during the period 2002-2009 in Yamagata prefecture, Japan. A phylogenetic tree reconstructed by the Bayesian Markov chain Monte Carlo method showed that the strains diversified at around 1946 and that the rate of molecular evolution was 1.10¾10
INTRODUCTION
Human parainfluenza virus type 3 (HPIV3) of the genus Respirovirus and family Paramyxoviridae causes acute respiratory illness (ARI) such as the common cold, croup, bronchiolitis and pneumonia (Karron & Collins, 2007) . Epidemiological data suggest that most young children are infected at least once with HPIV and that reinfections occur throughout life (Griffin et al., 2004; Moscona, 2005) .
Indeed, serological surveys indicate that at least 60 % of children have been infected with HPIV3 by 2 years of age and approximately 80 % have been infected by the age of 4 (Parrott et al., 1962) . HPIV is associated with up to 12 % of acute lower respiratory tract infections in adults (Azevedo et al., 2003; Matsuse et al., 2005) and may be associated with virus-induced asthma (Kusel et al., 2007) . HPIV3 can also present as a refractory airway disease (Rosenthal et al., 2010) . Thus, in addition to respiratory syncytial virus, HPIV3 is a common major agent of ARI and its resulting complications in children (Jartti et al., 2007; Kusel et al., 2007) . in the form of neuraminidase (Henrickson, 2003; Moscona, 2005) , and regulates virus adsorption, entry and budding of HPIV (Moscona, 2005) . In addition, the HN glycoprotein might function as a major antigen (Henrickson, 2003; Karron & Collins, 2007) . Previous reports have shown that its active/catalytic sites might essentially possess both receptor-binding and neuraminidase activities (Lawrence et al., 2004; Palermo et al., 2007; Porotto et al., 2007) . Substitutions of amino acids at these sites could be associated with both their molecular functions and molecular evolution. Analysis of the HN glycoprotein in HPIV3 would help to clarify this. However, little is known about the longitudinal molecular evolution of this glycoprotein in HPIV3 to date.
The Bayesian Markov chain Monte Carlo (MCMC) method enables the evolutionary timescale to be estimated (Thorne et al., 1998; Lepage et al., 2007) . Using this method, we conducted detailed analysis of the HN gene in HPIV3 isolated from children with ARI in Yamagata prefecture, Japan.
METHODS
Patients and isolation of HPIV3. We obtained 272 HPIV3 isolates from patients referred to paediatric clinics in Yamagata prefecture during the period 2002-2009. Informed consent was obtained from the parents of all subjects for the donation of samples used in this study. All patients were aged from 0 to 15 years (2.3±3.0 years; mean±SD). Patients were mainly diagnosed with upper respiratory tract infection (URI) (also known as the common cold), wheezy bronchitis, croup and pneumonia (Table 1 ). The diagnosis of ARIs was conducted as described previously (Cherry, 2003; Robert, 2003) .
Cell culture and virus isolation. To isolate the various respiratory viruses in this study, we used HEF, HEp-2, Vero E6, MDCK, RD18S, GMK and HMV-II cells. Cells were grown in Eagle's minimum essential medium or Roswell Park Memorial Institute medium (Nissui no. 3; Nissui Pharmaceutical Co.) in 5-10 % FBS or calf serum at 37 uC in a humidified atmosphere of 5 % CO 2 (Mizuta et al., 2008) . Cells were grown in 96-well microplates (Greiner Bio-One), inoculated with throat and nasal swabs from patients and incubated at 33 uC in a humidified atmosphere of 5 % CO 2 (Mizuta et al., 2008) . We observed the plates two to three times per week. When a suspected HPIV cytopathic effect was observed or a haemagglutinin adsorption test was positive, we harvested the culture supernatant and stored it at 280 uC until analysis.
RNA extraction, reverse-transcription PCR and sequencing.
RNA extraction and reverse-transcription PCR were carried out as described previously (Mizuta et al., 2010) . Briefly, viral RNA was extracted from 200 ml viral culture fluid using ISOGEN (Nippon Gene). Viral RNA was then transcribed into cDNA with Moloney murine leukemia virus reverse transcriptase (Nippon Gene) and a random primer (Takara Bio). Reverse transcription was carried out at 30 uC for 10 min, followed by incubation at 37 uC for 45 min and then incubation at 95 uC for 5 min. Using the cDNA, a part of the HN coding region was amplified by PCR for 40 cycles of 94 uC for 30 s, 55 uC for 30 s and 72 uC for 1 min, with a final extension at 72 uC for 10 min. Primer sets were newly designed by Primer Express version 1.5 software (Applied Biosystems) (Itagaki et al., 2010) . Primer sequences were as follows: first primer pair, 59-ATGAT-CTAATACARTCAGGAGTRAATACAAG-39 (primer HPIV-3USF, nt 70687-70098) and 59-ACAACAATRATRGARTTGACCATCCT-39 (primer HPIV-3USR, nt 79317-79956); second primer pair, 59-CAYCAGGCATAGAAGATMTTGTACTTG-39 (primer HPIV-3MSF, nt 76507-76676) and 59-YGCTTTTVTGATTTATTTCTACTATRT-GRAAACAATA-39 (primer HPIV-3MSR, nt 84328-84468); and third primer pair, 59-GTGYTATCAAGACCAGGAAACAATGA-39 (primer HPIV-3DSF, nt 81658-81190) and 59-TGGAAYCTCTGKYTTRAA-CAACAT-39 (primer HPIV-3DSR, nt 84868-84509). We analysed the nucleotide sequences (nt 71428-71493, 1352 nt) of the HN coding region. These sequences fully recovered the active/catalytic site of the gene (Lawrence et al., 2004) .
Phylogenetic analysis by the Bayesian MCMC method. To estimate the rate of molecular evolution (and hence a timescale) and evolutionary relationships, phylogenetic analyses were performed using the Bayesian MCMC method in the BEAST program (version 1.7.2) (Drummond & Rambaut, 2007) . Nucleotide sequences sharing 100 % similarity were removed from the dataset by analysing the alignment. The time of the most recent common ancestor with a 95 % highest posterior density was estimated by Bayesian molecular dating as described previously (Thorne et al., 1998; Lepage et al., 2007) . The HPIV3 sequences were aligned using MEGA software (version 5; available at: http://www.megasoftware.net/). We removed identical sequences from within the HPIV3 HN coding region of the genotype strains. The dataset was analysed under a log-normal relaxed uncorrelated clock using the general time reversible (GTR) model with the gamma distributed rates across sites (GTR+C) model selected by the KAKUSAN4 program (version 4.0) (Yang, 1994a, b) . The MCMC chain was run for 3610 7 steps and sampled every 10 3 steps. Uncertainty in the estimates was indicated by the 95 % highest posterior density intervals. The parameter outputs generated by the Bayesian MCMC runs and convergence on the basis of the effective sampling size after a 10 % burn-in were analysed using the TRACER program (version 1.5; available at: http://tree.bio.ed.ac.uk/software/ tracer). The trees were summarized in a target tree using the Tree Annotator program (version 1.7.2) by choosing the tree with the maximum posterior probabilities after a 10 % burn-in. selections were predicted using these models. The P value was used to classify a site as positively or negatively selected by these methods. Positive selection (d N .d S ) was determined by a P value of ,0.1 (SLAC, FEL). In addition, we calculated the pairwise distances for all strains, including the present isolates and reference strains, to assess the frequency distribution among all HPIV3 strains and that of each interlineage of HPIV3, as described previously (Mizuta et al., 2010) .
RESULTS
Phylogenetic analysis, using the Bayesian MCMC method, of the HN coding region of HPIV3
The partial nucleotide sequences (1352 nt) of the HN coding region in a total of 181 isolates and 14 reference strains were analysed using the Bayesian MCMC method. Phylogenetic trees based on the nucleotide sequence for the present and reference strains of HPIV3 could be classified into three lineages. The phylogenetic tree reconstructed using the Bayesian MCMC method with the nucleotide sequences of the HN coding region (1352 nt) is shown in Fig. 1 ).
Pairwise distances and identity of the HN coding region of HPIV3
We calculated the interspecies and interlineage distances and the identity of HPIV3 from the distribution of the pairwise distances. Based on the nucleotide sequences, the interspecies pairwise distance was 0.029±0.017 (mean±SD; Fig. 2a ) for the present and reference strains. Interlineage pairwise distances were 0.015±0.008 for lineage 1 (Fig. 2b) , 0.008±0.004 for lineage 2 (Fig. 2c) and 0.025±0.015 for lineage 3 (Fig. 2d) . The largest pairwise interlineage distance was that for lineage 3, whereas the shortest was that for lineage 2. In addition, the present strains showed high levels of identity in both nucleotide and amino acid sequences (nucleotide levels, 92.9-100 %; amino acid levels, 96.3-100 %).
Alterations of active/catalytic sites and positively selected sites of the HN glycoprotein in HPIV3
It has been suggested that the HN glycoprotein has two essential sites: site I has haemagglutinin and neuraminidase activity, and site II involves a second binding site (Lawrence et al., 2004; Palermo et al., 2007; Porotto et al., 2007) . Furthermore, there are 15 active/catalytic sites (Lawrence et al., 2004) . We analysed substitutions of these active/catalytic sites in the present strains, and details of the substitutions are shown in Table 2 . Briefly, five strains had the substitution R192G, three had R192I, three had K254E, one had K254T, seven had K254Q, one had N551D and two had H552Q. However, there were no amino acid substitutions at 11 antigenic sites (aa 193, 208, 215, 216, 276, 319, 409, 424, 502, 530 and 549) . Among these, only one substitution site (R192G or I) in the present strains may be unique compared with strains detected in other countries. In addition, no specific amino acid changes were seen among the clinical isolates from severe cases (i.e. croup or pneumonia). These results suggested that amino acid substitutions in active/catalytic sites had occurred in some strains of HPIV3. In addition, using the SLAC and FEL methods, we estimated that five positions in the HN gene were under positive selection pressure (Table 3) .
DISCUSSION
We studied molecular evolution of the HN gene in 272 HPIV3 isolates from ARI in Yamagata, Japan, during the period 2002-2009. First, a phylogenetic tree reconstructed by the Bayesian MCMC method showed that the present HPIV3 isolates were divisible into three lineages, with the first major division occurring around 1946 and producing these three lineages (Fig. 1) . After 2000, the strains belonging to two of the major lineages (lineages 1 and 2) subdivided into many clusters. The rate of molecular evolution (1.10610 23 substitutions per site per year) in the present strains may be similar to that of other virus genes such as the G gene of respiratory syncytial virus (Yoshida et al., 2012) . In addition, overall a high level of homology was found in both nucleotide and amino acid sequences of the HN glycoprotein in the present HPIV3 isolates. However, substitutions in the key residues thought to be important in HN glycoprotein biological activities were found in some strains of HPIV3. Notably, some key amino acid substitutions relating to active/catalytic sites or detailed structure-related amino acids were found. We also found five positive selection sites in the HN gene. The pairwise distances may correspond to the genetic distances among the strains. As suggested by this study and others, most of the mutations found in the HN gene of HPIV are common (Yang et al., 2011) . Based on our results, we speculate that the mutations in the HN gene of most of the HPIV3 strains detected in various countries including Japan proceed in a stepwise manner. Thus, the pairwise distances of the HN genes in these strains may be short, whilst the genetic evolution rate was relatively rapid. These results suggest that the molecular evolution of the HN coding region was relatively fast in the present HPIV3 strains.
The present phylogenetic tree showed that the 272 HPIV3 isolates were divided into three lineages. A recent study showed three distinct clusters in the phylogenetic tree based on the HPIV3 HN coding region (Mao et al., 2012) . In the present study, the number of strains belonging to lineage 3 was small, and most of the reference strains in this lineage were isolated in the middle of the last century (Mao et al., 2012) . By contrast, the strains belonging to the other two major lineages (lineages 1 and 2) were isolated relatively recently. Thus, the present results concur with those of this earlier report (Mao et al., 2012) .
Previous reports have suggested that site I of the HN glycoprotein involves both binding and neuraminidase activities, whilst site II involves a second receptor-binding site (Palermo et al., 2007; Porotto et al., 2007) . In particular, some amino acid substitutions in these sites affect active/catalytic activities (Palermo et al., 2007; Porotto et al., 2007) . For example, substitutions at T193 and D216 in site I and substitutions at H552 and N551 in site II significantly change the active/catalytic activities (Palermo et al., 2007; Porotto et al., 2007) . We found some important amino acid substitutions in the active/catalytic site of the HN protein in the present study. For example, R192 is one of three arginyl side chains (R192, R424 and R502) that project into one end of a cavity in the HN protein. A substitution of R192G or I of the HN gene may be a novel observation, and if the site is positively selected, this mutation might be associated with a change in the antigenicity of HPIV3. Moreover, the H552 and Q559 residues are located on the HN dimer interface, near the second active site. H552Q binds to its receptor more avidly, activates F protein more efficiently, fuses in monolayer culture more extensively and physically interacts with the F protein more strongly (Tappert et al., 2011; Mao et al., 2012) . A recent study suggested that the H552Q mutation confers higher avidity to receptors, whilst the introduction of Q559R into the HN protein has the opposite effect. In addition, Q559 might disrupt the dimer observed in the crystal structure (Palmer et al., 2012) . Taken together, to acquire a better understanding of the importance of these mutations, more detailed analyses on the changes in the structure, catalytic activities and antigenicity of the HPIV3 HN protein are needed.
HPIV is classified into four serotypes (HPIV1-4), all of which can cause various ARI in humans, such as URI, croup, bronchitis and pneumonia (Karron & Collins, 2007) . A previous report suggested that HPIV1 and -3 are the dominant viruses in children with ARI (Reed et al., 1997) . Whilst HPIV1 was divided into two major lineages in a previous study (Mizuta et al., 2011) , HPIV3 was divided into three major lineages in the present one. Moreover, although the Bayesian MCMC method in the present study showed that the first major division occurred around 1946 in HPIV3, it was estimated at 1950 in HPIV1 in the previous study (Mizuta et al., 2011) . The reason for Molecular evolution of the HN gene in HPIV3 these differences is unclear at present. In addition, the rate of molecular evolution in the present HPIV3 strains was found to be relatively high (1.10610 23 substitutions per site per year) compared with HPIV1 (7.68610 24 substitutions per site per year) (Mizuta et al., 2011) . This may be due to differences in the methods of estimation used (maximum-likelihood method vs Bayesian MCMC method). Thus, it may be difficult to compare the previous and present data. Taken together, further detailed studies of the viral genome and additional sequence data are required to elucidate the molecular evolution of HPIV3.
In conclusion, although HPIV is a major causative agent in ARI, the detailed molecular epidemiology of HPIV types, including HPIV3, is not well understood. Our results suggest that the HN gene is well conserved in the present HPIV3 strains compared with other major respiratory viruses such as influenza virus. However, the biological function and detailed structure of the HN glycoprotein in some of the strains may have been altered due to coding-region substitutions. To date, as little information is available on the molecular evolution of the HN gene in HPIV1-4, further studies are warranted to elucidate the molecular evolution of the major functional proteins in HPIVs.
